TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Changes In Cooperative Groups As Result Of Move To DCT Topic Of Chairmen’s Meeting Sept. 16 August 22, 1975